Lancashire and South Cumbria
Formulary
Home
Admin
netFormulary
Chapters
Medicines A-Z
News
Mobile
Reports
Feedback
Search
Results
Looking for
Alemtuzumab
found
3 matches
Open monograph to display formulary status
BNF Category
Alemtuzumab
(Lemtrada
®
)
Malignant disease and immunosuppression - Anti-lymphocyte monoclonal antibodies - 08.02.03
Links
Link to Drug Section
Link to document
MHRA: Lemtrada (alemtuzumab) and serious cardiovascular and immune-mediated adverse reactions: new restrictions to use and strengthened monitoring requirements (08.02.03)
NICE TA312: Alemtuzumab for treating highly active relapsing–remitting multiple sclerosis (08.02.03)
Alemtuzumab
(Lemtrada®)
